March 14, 2017
Daiichi Sankyo said on March 13 that it has launched a large-scale observational study of venous thromboembolism (VTE) in cancer patients, called Cancer-VTE Registry, which is designed to enroll and follow up to 10,000 cancer patients for one year to...read more